Jane Street
ZBIO

Jane Street’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History

Jane Street’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17,800
Closed -$406K – 5708
2017
Q4 		$406K Buy
17,800
+5,000
+39% +$116K ﹤0.01% 3428
2017
Q3 		$266K Buy
12,800
+7,250
+131% +$174K ﹤0.01% 3825
2017
Q2 		$149K Sell
5,550
-1,950
-26% -$63.1K ﹤0.01% 4103
2017
Q1 		$251K Sell
7,500
-3,500
-32% -$129K ﹤0.01% 3632
2016
Q4 		$528K Buy
11,000
+3,500
+47% +$165K ﹤0.01% 2809
2016
Q3 		$317K Sell
7,500
-39,150
-84% -$1.81M ﹤0.01% 3249
2016
Q2 		$3.02M Sell
46,650
-20,050
-30% -$1.23M 0.01% 937
2016
Q1 		$4.83M Buy
66,700
+58,200
+685% +$4.31M 0.03% 585
2015
Q4 		$349K Buy
+8,500
New +$418K ﹤0.01% 2906

Other funds holding ZBIO

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Jane Street's ZBIO Position: Q2 2019 in Review

Jane Street sold out of ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) in Q2 2019, closing a stake of 13,247 shares — an estimated $176K sold.

Jane Street first reported a position in ZBIO in Q3 2015 and held it in 11 quarters. The position peaked at $769K in Q1 2016. 5 funds tracked by Wall St. Rank hold ZBIO as of Q2 2019.

  • Jane Street reported no remaining ProShares UltraPro Short NASDAQ Biotechnology position as of Q2 2019 after selling out during the quarter.
  • Jane Street sold 13,247 ProShares UltraPro Short NASDAQ Biotechnology shares in Q2 2019, an estimated $176K.
  • Jane Street first reported a position in ProShares UltraPro Short NASDAQ Biotechnology in Q3 2015 and held it in 11 quarters.
  • Jane Street's ProShares UltraPro Short NASDAQ Biotechnology position peaked at $769K in Q1 2016.
  • 5 funds tracked by Wall St. Rank held ProShares UltraPro Short NASDAQ Biotechnology as of Q2 2019.

Based on Jane Street's 13F filing for Q2 2019, filed 15 Aug 2019.